Jacobs Levy Equity Management, Inc Ionis Pharmaceuticals Inc Transaction History
Jacobs Levy Equity Management, Inc
- $24.7 Billion
- Q3 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 650,779 shares of IONS stock, worth $22.1 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
650,779
Previous 572,870
13.6%
Holding current value
$22.1 Million
Previous $27.3 Million
4.51%
% of portfolio
0.11%
Previous 0.12%
Shares
23 transactions
Others Institutions Holding IONS
# of Institutions
402Shares Held
136MCall Options Held
862KPut Options Held
582K-
Vanguard Group Inc Valley Forge, PA15.1MShares$512 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$482 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$351 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$297 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$268 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.83B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...